116 related articles for article (PubMed ID: 38319157)
1. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
Nummela P; Zafar S; Veikkolainen E; Ukkola I; Cinella V; Ayo A; Asghar MY; Välimäki N; Törnquist K; Karhu A; Laakkonen P; Aaltonen LA; Ristimäki A
Int J Cancer; 2024 Jun; 154(11):1987-1998. PubMed ID: 38319157
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
3. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
4. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
Wilson CH; McIntyre RE; Arends MJ; Adams DJ
Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
[TBL] [Abstract][Full Text] [Related]
5. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
6. A novel
Watanabe K; Nakamura T; Onodera S; Saito A; Shibahara T; Azuma T
Tumour Biol; 2020 Sep; 42(9):1010428320962588. PubMed ID: 32996421
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway.
Kim DU; Nam J; Cha MD; Kim SW
Oncol Lett; 2019 Mar; 17(3):3589-3598. PubMed ID: 30867802
[TBL] [Abstract][Full Text] [Related]
8. Oncogene addiction to GNAS in GNAS
More A; Ito I; Haridas V; Chowdhury S; Gu Y; Dickson P; Fowlkes N; Shen JP
Oncogene; 2022 Aug; 41(35):4159-4168. PubMed ID: 35879396
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
Tsunoda T; Ota T; Fujimoto T; Doi K; Tanaka Y; Yoshida Y; Ogawa M; Matsuzaki H; Hamabashiri M; Tyson DR; Kuroki M; Miyamoto S; Shirasawa S
Mol Cancer; 2012 Jul; 11():46. PubMed ID: 22830422
[TBL] [Abstract][Full Text] [Related]
10. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.
Komatsu H; Tanji E; Sakata N; Aoki T; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M; Furukawa T
PLoS One; 2014; 9(2):e87875. PubMed ID: 24498386
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
12. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
14. Absence of GNAS mutation in colorectal carcinogenesis.
Lee H; La BM; Hwang I; Kang YN; Choi IJ; Lee JH
Tumori; 2017 Mar; 103(2):209-211. PubMed ID: 26350188
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
[TBL] [Abstract][Full Text] [Related]
16. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
Kim DU; Kwak B; Kim SW
Biochem Biophys Res Commun; 2019 Jan; 508(3):825-831. PubMed ID: 30528730
[TBL] [Abstract][Full Text] [Related]
19. Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering.
Xu R; Fu J; Hu Y; Yang X; Tao X; Chen L; Huang K; Fu Q
Diabetes; 2022 Aug; 71(8):1660-1678. PubMed ID: 35594380
[TBL] [Abstract][Full Text] [Related]
20. Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.
Miklos W; Heffeter P; Pirker C; Hager S; Kowol CR; van Schoonhoven S; Stojanovic M; Keppler BK; Berger W
Oncotarget; 2016 Dec; 7(51):84556-84574. PubMed ID: 27602951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
